Literature DB >> 32409347

Anti-HER2 therapy-associated cardiotoxicity in breast cancer patients: analysis of real-world data from a UK cancer centre.

Agathoklis Efthymiadis1, May Teoh2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32409347      PMCID： PMC7243516          DOI： 10.7861/clinmed.20-2-s20

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  5 in total

1.  Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial.

Authors:  Marion Procter; Thomas M Suter; Evandro de Azambuja; Urania Dafni; Veerle van Dooren; Susanne Muehlbauer; Miguel Angel Climent; Ernst Rechberger; Walter Tsang-Wu Liu; Mazakasu Toi; R Charles Coombes; David Dodwell; Olivia Pagani; Jorge Madrid; Marcia Hall; Shin-Cheh Chen; Christian Focan; Michael Muschol; Dirk J van Veldhuisen; Martine J Piccart-Gebhart
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

2.  Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial.

Authors:  Pooja P Advani; Karla V Ballman; Travis J Dockter; Gerardo Colon-Otero; Edith A Perez
Journal:  J Clin Oncol       Date:  2015-09-21       Impact factor: 44.544

3.  Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.

Authors:  Jersey Chen; Jessica B Long; Arti Hurria; Cynthia Owusu; Richard M Steingart; Cary P Gross
Journal:  J Am Coll Cardiol       Date:  2012-11-14       Impact factor: 24.094

Review 4.  Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging.

Authors:  Michelle W Bloom; Carine E Hamo; Daniela Cardinale; Bonnie Ky; Anju Nohria; Lea Baer; Hal Skopicki; Daniel J Lenihan; Mihai Gheorghiade; Alexander R Lyon; Javed Butler
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

5.  Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.

Authors:  Erin J Aiello Bowles; Robert Wellman; Heather Spencer Feigelson; Adedayo A Onitilo; Andrew N Freedman; Thomas Delate; Larry A Allen; Larissa Nekhlyudov; Katrina A B Goddard; Robert L Davis; Laurel A Habel; Marianne Ulcickas Yood; Catherine McCarty; David J Magid; Edward H Wagner
Journal:  J Natl Cancer Inst       Date:  2012-09-05       Impact factor: 13.506
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.